| Trial ID: | L4980 |
| Source ID: | NCT02192684
|
| Associated Drug: |
Pioglitazone
|
| Title: |
Obesity, Sleep Apnea, and Insulin Resistance
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT02192684/results
|
| Conditions: |
Insulin Sensitivity|Obstructive Sleep Apnea
|
| Interventions: |
DRUG: Pioglitazone|DRUG: placebo
|
| Outcome Measures: |
Primary: Change in Apnea-hypopnea Index (AHI) Outcome Measure in Response to Pioglitazone or Placebo, To evaluate the effects of pioglitazone versus placebo on AHI in patients with OSA., 8 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Stanford University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
45
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: OTHER
|
| Start Date: |
2010-09
|
| Completion Date: |
2015-03
|
| Results First Posted: |
2017-04-21
|
| Last Update Posted: |
2017-04-21
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT02192684
|
